Unichem Laboratories Limited
NSE: UNICHEMLAB BSE: UNICHEMLAB
NSE
468.00
0.85 (0.18%)
Prev Close
467.15
Open Price
465.65
Volume
7,973
Today Low / High
461.6 / 471.95
52 WK Low / High
444 / 867.85
Range
445 - 491
BSE
472.15
-0.55 (-0.12%)
Prev Close
472.7
Open Price
464.55
Volume
599
Today Low / High
463.8 / 477.2
52 WK Low / High
438.5 / 863
Range
449 - 496
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 468 (target range: 445 - 491), reflecting a change of 0.85 (0.18195%). On the BSE, it is listed at 472.15 (target range: 449 - 496), showing a change of -0.55 (-0.11635%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
28 Nov
465.65
0.32%
27 Nov
474.00
-1.45%
26 Nov
472.95
-0.77%
25 Nov
455.95
3.41%
24 Nov
462.00
-1.26%
21 Nov
473.45
-1.49%
19 Nov
477.00
1.09%
18 Nov
473.20
0.80%
17 Nov
468.00
1.88%
14 Nov
469.30
-0.68%
13 Nov
479.65
-2.10%
12 Nov
479.00
0.14%
11 Nov
462.00
4.31%
10 Nov
460.00
0.46%
07 Nov
463.00
-0.63%
06 Nov
467.00
0.65%
04 Nov
475.15
-1.59%
03 Nov
470.00
1.10%
Unichem Laboratories Limited Graph
Unichem Laboratories Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Unichem Laboratories Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 468.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 472.15 | 476.87 | 429.18 - 524.56 |
| 481.59 | 385.27 - 577.91 | ||
| 486.31 | 340.42 - 632.21 | ||
| Bearish Scenario | 472.15 | 467.43 | 420.69 - 514.17 |
| 462.71 | 370.17 - 555.25 | ||
| 457.99 | 320.59 - 595.38 |
Overview of Unichem Laboratories Limited
ISIN
INE351A01035
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
23,015
Market Cap
32,949,891,000
Last Dividend
0
Official Website
IPO Date
2002-07-01
DCF Diff
N/A
DCF
0
Financial Ratios Every Investor Needs
Stock Dividend of UNICHEMLAB
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2022-08-01 | August 01, 22 | 4 | 4 | 2022-08-02 | 2022-08-20 | |
| 2021-07-22 | July 22, 21 | 4 | 4 | 2021-07-24 | 2021-08-30 | |
| 2020-08-20 | August 20, 20 | 4 | 4 | 2020-08-22 | 2020-09-04 | |
| 2019-07-18 | July 18, 19 | 4 | 4 | 2019-07-20 | 2019-08-02 | |
| 2018-07-19 | July 19, 18 | 5 | 5 | 2018-07-21 | 2018-08-03 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2,110.97 Cr | 863.67 Cr | 1,247.30 Cr | 0.5909 | 18.51 Cr | 403.97 Cr | 845.09 Cr | 137.52 Cr | 19.53 | 264.86 Cr | 0.0651 |
| 2024-03-31 | 1,657.42 Cr | 1,339.98 Cr | 317.43 Cr | 0.1915 | 104.67 Cr | 43.29 Cr | -12.99 Cr | -70.47 Cr | -10.01 | 74.24 Cr | -0.0425 |
| 2023-03-31 | 1,325.45 Cr | 550.93 Cr | 792.10 Cr | 0.5976 | 109.40 Cr | 33.32 Cr | -172.88 Cr | -202.23 Cr | -28.73 | -45.61 Cr | -0.1526 |
| 2022-03-31 | 1,255.74 Cr | 440.54 Cr | 807.44 Cr | 0.6430 | 112.74 Cr | 32.48 Cr | -24.36 Cr | 33.06 Cr | 4.70 | 118.22 Cr | 0.0263 |
| 2021-03-31 | 1,204.87 Cr | 401.37 Cr | 788.55 Cr | 0.6545 | 129.91 Cr | 36.42 Cr | -19.71 Cr | 34.32 Cr | 4.88 | 141.23 Cr | 0.0285 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 89.58 Cr | 3,569.40 Cr | 1,118.81 Cr | 2,450.5900 Cr | 459.77 Cr | 342.14 Cr | 988.74 Cr | 1,309.99 Cr | 0.97 Cr | 0.64 Cr | 0.02 Cr | 994.3100 Cr |
| 2024-03-31 | 150.91 Cr | 3,169.34 Cr | 806.93 Cr | 2,362.4188 Cr | 247.51 Cr | 96.60 Cr | 704.68 Cr | 1,324.21 Cr | 7.69 Cr | 0.87 Cr | -1.32 Cr | 707.8787 Cr |
| 2023-03-31 | 183.75 Cr | 3,193.05 Cr | 757.74 Cr | 2,435.3041 Cr | 314.05 Cr | 130.29 Cr | 625.23 Cr | 1,402.57 Cr | 58.12 Cr | 1.10 Cr | 1.62 Cr | 639.6008 Cr |
| 2022-03-31 | 109.20 Cr | 3,318.77 Cr | 700.36 Cr | 2,618.4110 Cr | 349.15 Cr | 239.96 Cr | 600.22 Cr | 1,482.30 Cr | 70.72 Cr | 4.69 Cr | 3.40 Cr | 552.1277 Cr |
| 2021-03-31 | 77.46 Cr | 3,125.71 Cr | 568.88 Cr | 2,556.8348 Cr | 119.09 Cr | 41.63 Cr | 538.34 Cr | 1,446.37 Cr | 134.27 Cr | 4.69 Cr | -80.84 Cr | 505.7611 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -7.0200 Cr | -241.2300 Cr | 183.7600 Cr | -144.3800 Cr | -65.5200 Cr | 89.5800 Cr | -137.3600 Cr | 137.5200 Cr | 209.5700 Cr | -0.3400 Cr | -252.4800 Cr |
| 2024-03-31 | 14.0000 Cr | 50.4043 Cr | -106.3113 Cr | -5.8533 Cr | -29.2110 Cr | 150.9124 Cr | -22.5473 Cr | -70.4743 Cr | -78.4796 Cr | -0.2135 Cr | -79.4469 Cr |
| 2023-03-31 | -85.0907 Cr | 202.8133 Cr | -81.2999 Cr | -129.4064 Cr | 74.5559 Cr | 183.7522 Cr | -44.3157 Cr | -176.3629 Cr | -33.3557 Cr | -28.2545 Cr | -25.0078 Cr |
| 2022-03-31 | -259.6120 Cr | 100.1193 Cr | 191.2282 Cr | -386.6144 Cr | 31.7355 Cr | 109.1963 Cr | -127.0024 Cr | 21.9689 Cr | 109.8250 Cr | -28.3615 Cr | -61.8817 Cr |
| 2021-03-31 | 33.0987 Cr | -73.5576 Cr | -121.1911 Cr | -254.7157 Cr | -154.0576 Cr | 77.4608 Cr | -287.8144 Cr | 51.4794 Cr | -83.4086 Cr | -28.6579 Cr | -141.7988 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 526.60 Cr | 245.05 Cr | 281.55 Cr | 0.5347 | -9.30 Cr | -10.47 Cr | -1.49 | 29.31 Cr | -0.0199 |
| 2025-03-31 | 587.18 Cr | 264.57 Cr | 322.61 Cr | 0.5494 | 54.01 Cr | 52.97 Cr | 7.52 | 92.62 Cr | 0.0902 |
| 2024-12-31 | 533.09 Cr | 191.52 Cr | 341.57 Cr | 0.6407 | 54.98 Cr | 57.85 Cr | 8.22 | 99.14 Cr | 0.1085 |
| 2024-09-30 | 462.16 Cr | 174.48 Cr | 287.68 Cr | 0.6225 | 28.99 Cr | 30.49 Cr | 4.34 | 66.32 Cr | 0.0660 |
| 2024-06-30 | 446.43 Cr | 326.99 Cr | 156.35 Cr | 0.3502 | 8.08 Cr | 9.26 Cr | 1.31 | 43.50 Cr | 0.0207 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 89.58 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -2,450.59 Cr |
| 2025-03-31 | 117.63 Cr | 0.00 Cr | 117.63 Cr | 778.81 Cr | 988.74 Cr | 2,037.95 Cr | 1,309.99 Cr | 3,569.40 Cr | 1,118.81 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 198.03 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -2,400.65 Cr |
| 2024-09-30 | 187.78 Cr | 10.64 Cr | 198.42 Cr | 630.45 Cr | 837.46 Cr | 1,823.47 Cr | 1,296.43 Cr | 3,310.96 Cr | 910.31 Cr |
| 2024-06-30 | 152.25 Cr | 0.00 Cr | 152.25 Cr | 0.00 Cr | 0.00 Cr | 152.25 Cr | 0.00 Cr | 0.00 Cr | -2,362.42 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | -10.47 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 52.97 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 57.85 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 30.49 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 9.26 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2010-10-21 | October 21, 10 | 5:2 |
| 2004-03-16 | March 16, 04 | 2:1 |
| 2001-07-03 | July 03, 01 | 2:1 |
| 2000-04-03 | April 03, 00 | 2:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,832.00 | ₹4,395,581,665,040.00 | ₹1,623,103.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,461.50 | ₹1,715,325,229,670.00 | ₹250,130.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,712.10 | ₹1,256,343,317,824.00 | ₹164,885.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,257.40 | ₹1,046,801,248,935.00 | ₹809,748.00 |
| Lupin Limited | LUPIN | ₹2,080.50 | ₹950,293,715,490.00 | ₹822,625.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹940.30 | ₹946,161,820,797.00 | ₹919,929.00 |
| Mankind Pharma Limited | MANKIND | ₹2,250.90 | ₹929,078,062,632.00 | ₹267,030.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,219.10 | ₹708,055,258,599.00 | ₹556,120.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,677.50 | ₹678,830,287,500.00 | ₹57,067.00 |
| Laurus Labs Limited | LAURUSLABS | ₹1,032.50 | ₹557,369,208,218.00 | ₹2,486,519.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,948.80 | ₹549,952,936,579.00 | ₹687,641.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,447.00 | ₹367,110,003,446.00 | ₹454,494.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,551.20 | ₹318,735,763,949.00 | ₹42,956.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,769.20 | ₹277,104,488,400.00 | ₹81,652.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,410.00 | ₹267,286,434,270.00 | ₹142,264.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹9,028.50 | ₹225,712,500,000.00 | ₹5,257.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹17,190.00 | ₹220,545,791,910.00 | ₹91,650.00 |
| Eris Lifesciences Limited | ERIS | ₹1,593.00 | ₹216,993,507,363.00 | ₹35,120.00 |
| Cohance Lifesciences Limited | COHANCE | ₹564.95 | ₹216,131,305,743.00 | ₹280,882.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,234.60 | ₹200,612,831,847.00 | ₹445,893.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹908.35 | ₹178,548,113,685.00 | ₹42,097.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,098.00 | ₹174,031,281,630.00 | ₹68,413.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹876.00 | ₹156,900,246,120.00 | ₹2,143,680.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,905.50 | ₹144,840,286,728.00 | ₹25,901.00 |
| Granules India Limited | GRANULES | ₹558.50 | ₹135,530,477,886.00 | ₹857,235.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹896.00 | ₹109,922,487,808.00 | ₹29,654.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,715.00 | ₹94,865,468,130.00 | ₹5,334.00 |
| Strides Pharma Science Limited | STAR | ₹880.80 | ₹81,185,726,491.00 | ₹133,346.00 |
| FDC Limited | FDC | ₹415.30 | ₹67,615,027,885.00 | ₹39,773.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹342.50 | ₹66,986,771,980.00 | ₹181,899.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹427.20 | ₹65,405,199,178.00 | ₹159,443.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹702.05 | ₹63,638,932,753.00 | ₹202,624.00 |
| Sequent Scientific Limited | SEQUENT | ₹224.65 | ₹56,122,920,938.00 | ₹1,211,340.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹408.00 | ₹44,457,828,120.00 | ₹87,415.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹134.13 | ₹43,528,080,598.00 | ₹222,843.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹835.00 | ₹42,350,452,675.00 | ₹126,902.00 |
| Innova Captab Limited | INNOVACAP | ₹718.10 | ₹41,093,221,515.00 | ₹9,801.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹425.00 | ₹38,789,750,000.00 | ₹113,381.00 |
| Suven Life Sciences Limited | SUVEN | ₹173.40 | ₹38,218,403,001.00 | ₹118,201.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,285.00 | ₹37,791,649,275.00 | ₹5,465.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹355.75 | ₹35,675,501,510.00 | ₹33,410.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹468.00 | ₹32,949,891,000.00 | ₹7,973.00 |
Key Executives
Chief Scientific & Compliance Officer
Dr. Dhananjay Sathe
Gender: Not Specified
Year Born:
Chief Manufacturing Officer of Formulations
Mr. Utkarsh Patil
Gender: male
Year Born:
Chief Financial Officer
Mr. Sanjay Jain
Gender: male
Year Born: 1978
Vice President of Human Resources & ER
Mr. Prasad Joshi
Gender: male
Year Born: 1958
Chief Executive of Domestic Pharma
Mr. Bhagwat S. Dhingra
Gender: male
Year Born: 1963
Chief Quality & Compliance Officer
Mr. Jalesh Burye
Gender: male
Year Born:
President & Chief Executive Officer of Unichem Pharmaceuticals (USA), Inc.
Mr. Scott B. Delaney
Gender: male
Year Born: 1969
MD & Director
Mr. Pabitra Kumar Kalipada Bhattacharyya
Gender: male
Year Born: 1969
Head of Legal, Company Secretary & Compliance Officer
Mr. Pradeep Kumar Bhandari
Gender: male
Year Born: 1958
Head of Projects & Investments
Mr. Vinod Kumar Behl
Gender: male
Year Born: 1950
FAQs about Unichem Laboratories Limited
Who is the CEO of the company?
The CEO is Scott B. Delaney.
What is the current market price of the stock?
The current price is ₹468.00.
What is the 52-week price range?
The range is ₹444-867.85.
What is the market capitalization of the company?
The market capitalization is ₹3,294.99 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 25.13.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Unichem Laboratories Limited (ISIN: INE351A01035) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹3,294.99 crores and an average daily volume of 23,015 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.